Alliance Global Partners lowered the firm’s price target on Canopy Growth to C$6 from C$10 on split-adjusted basis and keeps a Neutral rating on the shares following Canopy’s fiscal Q3, which the firm says “demonstrated progress towards its goals.” Near-term, the firm lowered its sales estimates for the divestiture of This Works, but looks for organic growth in the company’s remaining segments.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CGC:
- Canopy Growth Reports Third Quarter Fiscal Year 2024 Financial Results; Achieves Third Quarter of Sequential Revenue Growth across Canada Cannabis Businesses and a Record Quarter for Medical Sales
- Options Volatility and Implied Earnings Moves Today, February 09, 2024
- Rising High: Exclusive talk with house of brands Carma HoldCo
- Is CGC a Buy, Before Earnings?
- Rising High: Exclusive talk with drug manufacturer Optimi Health
